Aspr-13-07507 -- SP-formulation fill of H7N9 clincial lots (15 30 and 60MCG ML) under contract HHSO201200015I
Ended Awarded Last action
- Contract number
- HHSO10033007T
- Awardee
-
Sanofi Vaccines US Inc. UEI NCXBGGQ8YTU9
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $772,708
Award facts
- Opportunity
-
- 11100SOL00020 Solicitation number
- Acquisition of MCMs for Pandemic Influenza Preparedness and Response Award Notice · Posted Jan 31, 2012
- Contract value 100% obligated
- $772,708.47 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Swiftwater, PA 18370, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$230,522 | |
| Change Order | $0 | |
| Change Order | $0 | |
| Original award | $1,003,230 |
About this award
This is a firm fixed price delivery order awarded to Sanofi Pasteur Inc. by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The contract supports the Acquisition of Medical Countermeasures for Pandemic Influenza Preparedness and Response program, with a ceiling value of $772,708.47. Sanofi Pasteur Inc., as the prime contractor, will provide formulation and fill services for H7N9 influenza vaccine clinical lots at 15 mcg/mL, 30 mcg/mL, and 60 mcg/mL dosage levels. This work is being conducted under a larger Indefinite Delivery Vehicle (IDV) contract from ASPR potentially valued at $5.87 billion to supply medical countermeasures for emerging health threats. The delivery order does not have a small business set-aside designation. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer of pharmaceutical products and vaccines.
Quick answers
Who was awarded contract HHSO10033007T?
HHSO10033007T was awarded to Sanofi Vaccines US Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on July 1, 2013.
How much is contract HHSO10033007T worth?
The government has obligated $772,708 on HHSO10033007T.
Is contract HHSO10033007T an order under another contract?
Yes. HHSO10033007T is a delivery order under HHSO100201200015I, an indefinite delivery contract, on Pandemic Influenza Preparedness and Response 2012-2016.
Was contract HHSO10033007T competed?
The extent of competition for HHSO10033007T was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award